Abstract
Objective
HALO radiofrequency ablation (RFA) has been proven as safe and efficient in eradication of both non- and dysplastic Barrett’s esophagus (BE). Definitive post-RFA treatment is yet to be determined.
Methods
RFA was performed in 56 patients with BE, 38 with intestinal metaplasia (IM) and 18 with low-grade dysplasia (LGD), and repeated in case of residual BE. Length of the BE was classified according to C&M criteria. Follow-up included regular upper GI endoscopies with biopsies 6 months, 1 and 2 years after the complete resolution of BE. Patients were divided into two groups regarding post-RFA treatment: those maintaining proton pump inhibitors (PPI) daily and those submitted to laparoscopic Nissen fundoplication (LNF) at least 3 months after BE eradication or synchronous with RFA.
Results
There were no perforations or strictures related to RFA. Complete endoscopic resolution of BE was observed in 83.92 % patients (86.84 % IM and 77.77 % LGD), in 25 that maintained PPI and 22 in whom LNF was done. In PPI group, 2-year follow-up revealed BE recurrence in biopsy samples in 20 % of patients, while in LNF group 9.1 % of patients had recurrent IM. In overall sample of patients, no difference was noted regarding the influence of post-RFA treatment (p < 0.423). LNF proved superiority over PPI treatment in patients with long-segment BE (cutoff C > 4 cm, p < 0.021).
Conclusion
HALO RFA is a safe procedure, with high rate of success in complete eradication of BE in symptomatic GERD patients. LNF provides good protection for neosquamous epithelium and in selected group of patients could be offered as a first line of treatment after HALO RFA.
Similar content being viewed by others
References
Spechler S, Souza R (2014) Barrett’s esophagus. N Engl J Med 371:836–845
Thrift AP, Whiteman DC (2014) The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 23:3155–3162
Peters JH, Hagen JA, DeMeester SR (2004) Barrett’s esophagus. J Gastrointest Surg 8:1–17
Wolfgarten E, Pütz B, Hölscher AH, Bollschweile E (2007) Duodeno-gastric-esophageal reflux—what is pathologic? Comparison of patients with Barrett’s esophagus and age-matched volunteers. J Gastrointest Surg 11:479–486
Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288
Fleischer DE, Overholt BF, Sharma VK et al (2010) Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 42:781–789
Orman ES, Li N, Shaheen NJ (2013) Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:1245–1255
Krishnan K, Pandolfino J, Kahrilas P, Keefer L, Boris L, Komunduri S (2012) Increased risk for persistent intestinal metaplasia in patients with Barrett’s esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 143:576–581
Triadafilopulos G (2008) Proton pump inhibitors in Barrett’s esophagus: pluripotent but controversial. Eur Surg 40:58–65
Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R (2009) Reflux patterns in patients with short-segment Barrett’s oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 30(5):508–515
Korst RJ, Santana-Joseph S, Rutledge JR, Antler A, Bethala V, DeLillo A, Kutner D, Lee BE, Pazwash H, Pittman RH, Rahmin M, Rubinoff M (2011) Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett’s esophagus: a single-center, phase II clinical trial. J Thorac Cardiovasc Surg 142:1168–1173
Gupta M, Iyer GP, Lutzke L, Gorospe EC, Abrams JA, Falk GW, Ginsberg GG, Rustgi AK, Lightdale CJ, Wang TC, Fudman DI, Poneros JM, Wang KK (2013) Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium recurrence of Barrett’s esophagus after EMR and RFA. Gastroenterology 145:79–86
Akiyama J, Marcus SN, Triadafilopoulos G (2012) Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett’s esophagus. Dig Dis Sci 57:2625–2632
Jovov B, Shaheen NJ, Orlando GS, Djukic Z, Orlando RC (2013) Defective barrier function in neosquamous epithelium. Am J Gastroenterol. doi:10.1038/ajg.2012.440
Raveli AM, Villanacci V, Ruzzenenti N, Grigolato P, Tobanelli P, Klersy C, Rindi G (2006) Dilated intercellular spaces: a major morphological feature of esophagitis. J Pediatr Gastroenterol Nutr 42:510–515
Orlando RC (2014) How good is the neosquamous epithelium? Dig Dis 32:164–170
O’Connell K, Velanovich V (2011) Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett’s esophagus. Surg Endosc 25:830–834
Johnson CS, Louie BE, Wille A, Dunst CM, Worrell SG, DeMeester SR, Reynolds J, Dixon J, Lipham JC, Lada M, Peters JH, Watson TJ, Farivar AS, Aye RW (2015) The durability of endoscopic therapy for treatment of Barrett’s metaplasia, dysplasia, and mucosal cancer after nissen fundoplication. J Gastrointest Surg 19:799–805
Korst RJ, Santana-Joseph S, Rutledge JR, Antler A, Bethala V, DeLillo A, Kutner D, Lee BE, Pazwash H, Pittman RH, Rahmin M, Rubinoff M (2013) Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett’s esophagus. J Thorac Cardiovasc Surg 145:1529–1534
Mashimo H (2013) Subsquamous intestinal metaplasia after ablation of Barrett’s esophagus: frequency and importance. Curr Opin Gastroenterol 29:454–459
Phoa KN, Pouw RE, van Vilsteren FG, Sondermeijer CM, Ten Kate FJ, Visser M, Meijer SL, van Berge Henegouwen MI, Weusten BL, Schoon EJ, Mallant-Hent RC, Bergman JJ (2013) Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 145:96–104
Vaccaro BJ, Gonzalez S, Poneros JM, Stevens PD, Capiak KM, Lightdale CJ, Abrams JA (2011) Detection of intestinal metaplasia after successful eradication of Barrett’s esophagus with radiofrequency ablation. Dig Dis Sci 56:1996–2000
Goers TA, Leão P, Cassera MA, Dunst CM, Swanström LL (2011) Concomitant endoscopic radiofrequency ablation and laparoscopic reflux operative results in more effective and efficient treatment of Barrett’s esophagus. J Am Coll Surg 213:486–492
Lenglinger J, Eisler M, Wrba F, Prager G, Zacherl J, Riegler M (2008) Update: histopathology-based definition of gastroesophageal reflux disease and Barrett’s esophagus. Eur Surg 40:165–175
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Ognjan Skrobic, Aleksandar Simić, Nebojsa Radovanovic, Nenad Ivanovic, Marjan Micev and Predrag Pesko have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Skrobić, O., Simić, A., Radovanović, N. et al. Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett’s esophagus. Surg Endosc 30, 3802–3807 (2016). https://doi.org/10.1007/s00464-015-4677-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4677-9